Urine and Plasma Osmolality in Patients with Autosomal Dominant Polycystic Kidney Disease: Reliable Indicators of Vasopressin Activity and Disease Prognosis?

Slides:



Advertisements
Similar presentations
Kühn, E W; Walz, G The Treatment of Autosomal Dominant Polycystic Kidney Disease Dtsch Arztebl Int 2015; 112(51-52): ; DOI: /arztebl
Advertisements

Date of download: 7/11/2016 From: Cost-Effectiveness of Tolvaptan in Autosomal Dominant Polycystic Kidney Disease Ann Intern Med. 2013;159(6):
© 2016 S. Karger AG, Basel. All rights reserved Metabolomics of Chronic Kidney Disease Progression: A Case-Control Analysis in the Chronic Renal Insufficiency.
Echocardiographic Changes in Patients with Stage 3-5 Chronic Kidney Disease and Left Ventricular Diastolic Dysfunction Cardiorenal Med 2014;4:
Case Rep Nephrol Dial 2016;6:128– DOI: / © 2016 The Author(s)
Maintenance Hemodialysis Using Native Arteriovenous Fistula in a Patient with Severe Generalized Recessive Dystrophic Epidermolysis Bullosa Case Rep Nephrol.
Public Health Genomics 2012;15:1–10 - DOI: /
Deferasirox Decreases Liver Iron Concentration in Iron-Overloaded Patients with Myelodysplastic Syndromes, Aplastic Anemia and Other Rare Anemias Acta.
Renalase, a Novel Enzyme Involved in Blood Pressure Regulation, Is Related to Kidney Function but Not to Blood Pressure in Hemodialysis Patients Kidney.
Are Sodium Transporters in Urinary Exosomes Reliable Markers of Tubular Sodium Reabsorption in Hypertensive Patients? Nephron Physiol 2010;114:p25–p34.
Effect of a Non-Calcium-Based Phosphate Binder on Fibroblast Growth Factor 23 in Chronic Kidney Disease Nephron Clin Pract 2013;123: DOI: /
Novel Methodology to Evaluate Renal Cysts in Polycystic Kidney Disease
The Longitudinal Study of Liver Cysts in Patients With Autosomal Dominant Polycystic Kidney Disease and Polycystic Liver Disease  Ryo Matsuura, Kenjiro.
Biochemical Predictors of Outcome of Pituitary Surgery for Cushing’s Disease Neuroendocrinology 2010;91:169–178 - DOI: / © 2009 S. Karger.
Multiple hepatic cysts in the setting of ADPKD
Am J Nephrol 2013;38: DOI: / Fig. 1. Study selection process.
Characteristics IgAN (n=28) ADPKD (n=37) Male (percentage) 21 (75.0)
Importance of Ferritin for Optimizing Anemia Therapy in Chronic Kidney Disease Am J Nephrol 2010;32:439–446 - DOI: / Fig. 1. Estimated.
Quantitative Renal Echogenicity as a Tool for Diagnosis of Advanced Chronic Kidney Disease in Patients with Glomerulopathies and no Liver Disease Kidney.
Maximizing the Benefit-Cost Ratio of Anthracyclines in Metastatic Breast Cancer: Case Report of a Patient with a Complete Response to High-Dose Doxorubicin.
Renal Parenchymal Hypoxia, Hypoxia Response and the Progression of Chronic Kidney Disease Am J Nephrol 2008;28:998– DOI: / © 2008.
Disease Progression Modeling to Evaluate the Effects of Enzyme Replacement Therapy on Kidney Function in Adult Patients with the Classic Phenotype of Fabry.
Diabetic Cardiovascular Disease Predicts Chronic Kidney Disease Awareness in the Kidney Early Evaluation Program Cardiorenal Med 2011;1:45–52 - DOI: /
Local Breast Cancer Recurrence after Mastectomy and Breast-Conserving Surgery for Paget's Disease: A Meta-Analysis Breast Care 2014;9: DOI: /
Creatinine-Based Glomerular Filtration Rates and Microalbuminuria for Detecting Metabolic Abnormalities in US Adults: The National Health and Nutrition.
Disposition of Erlotinib and Its Metabolite OSI420 in a Patient with High Bilirubin Levels Case Rep Oncol 2013;6: DOI: / Fig.
Significance of Urine Diagnostic Tests After Renal Transplantation
Plasma Cell Leukemia Presenting as a Chest Wall Mass: A Case Report
T-Cell Lymphoma in a Patient with Neurofibromatosis Type 1 and AIDS
Cell Physiol Biochem 2016;40: DOI: /
Nebivolol Reduces Proteinuria and Renal NADPH Oxidase-Generated Reactive Oxygen Species in the Transgenic Ren2 Rat Am J Nephrol 2009;30:354–360 - DOI: /
Magnesium Replacement Improves the Metabolic Profile in Obese and Pre-Diabetic Patients with Mild-to-Moderate Chronic Kidney Disease: A 3-Month, Randomised,
The Impact of Case Finding on the Recruitment Yield for COPD Research in Primary Care: An Observational Study Respiration 2016;92: DOI: /
Evaluating Quality in Clinical Cancer Research: The M. D
Pulmonary Hypertension Is Associated with Mortality and Cardiovascular Events in Chronic Kidney Disease Patients Am J Nephrol 2017;45: DOI: /
Current status of end-stage renal disease care in India and Pakistan
Effect of Food Insecurity on Chronic Kidney Disease in Lower-Income Americans Am J Nephrol 2014;39: DOI: / Fig. 1. Age-adjusted.
Metabolomics of Chronic Kidney Disease Progression: A Case-Control Analysis in the Chronic Renal Insufficiency Cohort Study Am J Nephrol 2016;43:
Electrochemotherapy in the Treatment of Massive, Multisite Breast Cancer Metastasis to the Skin and Subcutaneous Tissue: A Case Report Breast Care 2016;11:
The Effect of Upper Airway Surgery on Continuous Positive Airway Pressure Levels and Adherence: A Systematic Review and Meta-Analysis ORL 2016;78:
Using Hemoglobin A1c to Derive Mean Blood Glucose in Peritoneal Dialysis Patients Am J Nephrol 2013;37: DOI: / Fig. 1. Comparison.
ZNF750 Expression Is a Potential Prognostic Biomarker in Esophageal Squamous Cell Carcinoma Oncology - DOI: / Fig. 1. The immunohistochemical.
Figure 4 The theoretical contribution of genetic and
Plasma Glycated Albumin Levels Clearly Detect Hearing Loss and Atherosclerosis in Patients with Impaired Fasting Glucose Med Princ Pract 2016;25:
Multiple Sclerosis Epidemiology in Middle East and North Africa: A Systematic Review and Meta-Analysis Neuroepidemiology 2015;44: DOI: /
Plasma Clearance.
High Resolution Ultrasonography for Assessment of Renal Cysts in the PCK Rat Model of Autosomal Recessive Polycystic Kidney Disease Kidney Blood Press.
Adjuvant Dose-Dense Chemotherapy in Breast Cancer: Standard of Care in High-Risk Patients Breast Care 2016;11: DOI: / Fig. 1. Strategies.
Volume 66, Issue 4, Pages (October 2004)
Nat. Rev. Nephrol. doi: /nrneph
Rationale and Design of a Clinical Trial Investigating Tolvaptan Safety and Efficacy in Autosomal Dominant Polycystic Kidney Disease Torres et al. Am J.
Current status of end-stage renal disease care in India and Pakistan
Hepatic Cysts in Autosomal Dominant Polycystic Kidney Disease
Robert W. Schrier, Kimberly K. McFann, Ann M. Johnson 
Hepatic Cysts in Autosomal Dominant Polycystic Kidney Disease
Triptolide-Containing Formulation in Patients With Autosomal Dominant Polycystic Kidney Disease and Proteinuria: An Uncontrolled Trial  Dongping Chen,
A Pathological Scoring System to Predict Renal Outcome in Diabetic Nephropathy Am J Nephrol 2015;41: DOI: / Fig. 1. Renal survival.
Nat. Rev. Nephrol. doi: /nrneph
Figure 6 Hypothetical effect of starting therapy for autosomal
Volume 82, Issue 10, Pages (November 2012)
Volume 59, Issue 5, Pages (May 2001)
Nowak et al. Am J Nephrol 2016;44: (DOI: / )
Copyright © 2013 Elsevier Inc. All rights reserved.
Volume 67, Issue 2, Pages (February 2005)
Progressive Renal Dysfunction due to IgG4-Related Kidney Disease Refractory to Steroid Therapy: A Case Report Case Rep Nephrol Dial 2019;9:1–7 - DOI: /
Digital Medicine: A Primer on Measurement
Representative transaxial thin computed tomography (CT) sections at mid, mid-low, and low levels of the heart from a control subject (left) showing normal.
Vasopressin antagonists in polycystic kidney disease
Volume 67, Issue 4, Pages (April 2005)
The pretest probability of disease decreases with age in individuals who are born with 50% risk for autosomal dominant polycystic kidney disease (ADPKD)
Presentation transcript:

Urine and Plasma Osmolality in Patients with Autosomal Dominant Polycystic Kidney Disease: Reliable Indicators of Vasopressin Activity and Disease Prognosis? Am J Nephrol 2015;41:248-256 - DOI:10.1159/000382081 Fig. 1. Association of 24-hour urine osmolality, Uosm/Posm ratio and plasma osmolality with copeptin concentration in ADPKD patients (overall n = 94, mGFR >60 ml/min/1.73 m2, n = 64, and mGFR ≤60 ml/min/1.73 m2, n = 30). Dashed line in upper panel represents a urine osmolality = 285 mOsmol/l, and the dashed line in the middle panel represents a urine osmolality equal to plasma osmolality. In the lower panel the association of plasma osmolality with copeptin concentration is shown separately for ADPKD patients with mGFR ≤60 ml/min/1.73 m2 (solid line) and >60 ml/min/1.73 m2 (dashed line). © 2015 S. Karger AG, Basel

Urine and Plasma Osmolality in Patients with Autosomal Dominant Polycystic Kidney Disease: Reliable Indicators of Vasopressin Activity and Disease Prognosis? Am J Nephrol 2015;41:248-256 - DOI:10.1159/000382081 Fig. 2. Associations of mGFR and TKV (log scale) with 24-hour urine osmolality, plasma osmolality and copeptin concentration in 94 ADPKD patients. © 2015 S. Karger AG, Basel